CVS Health (CVS) Q3 2025 Earnings
CVS Health reported Q3 2025 revenue of $102.87B (+7.8% YoY), beat analyst consensus of $98.8B by $4.1B. Diluted EPS came in at $1.60 (+46.8% YoY), beat the $1.37 consensus by $0.23. CVS Health reports across 3 business segments, led by Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.
Financial Snapshot
Trailing eight quarters through Q3 2025
Q3 2025 Earnings FAQ
Common questions about CVS Health's Q3 2025 earnings report.
CVS Health (CVS) reported Q3 2025 earnings on October 29, 2025 before market open.
CVS Health reported revenue of $102.87B and diluted EPS of $1.60 for Q3 2025.
Revenue beat the consensus estimate of $98.8B by $4.1B. EPS beat the consensus estimate of $1.37 by $0.23.
Compared to the same quarter a year prior, revenue grew 7.8% from $95.4B a year earlier and diluted EPS grew 46.8% from $1.09.
You can read the 10-Q periodic report (0000064803-25-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.